Preclinical Species and Human Disposition of (1S,2S,3S,4R,5S)-5-(4-Chloro-3-(4- ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol (PF- 04971729), a Selective Inhibitor of the Sodium-Dependent Glucose Cotransporter 2 (SGLT2) and Clinical Candidate for the Treatment of Type 2 Diabetes Mellitus